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Abstract
Prion diseases like Creutzfeldt-Jakob disease in humans, Scrapie in sheep or bovine spongiform encephalopathy are fatal
neurodegenerative diseases, which can be of sporadic, genetic, or infectious origin. Prion diseases are transmissible
between different species, however, with a variable species barrier. The key event of prion amplification is the conversion of
the cellular isoform of the prion protein (PrP
C) into the pathogenic isoform (PrP
Sc). We developed a sodiumdodecylsulfate-
based PrP conversion system that induces amyloid fibril formation from soluble a-helical structured recombinant PrP
(recPrP). This approach was extended applying pre-purified PrP
Sc as seeds which accelerate fibrillization of recPrP. In the
present study we investigated the interspecies coherence of prion disease. Therefore we used PrP
Sc from different species
like Syrian hamster, cattle, mouse and sheep and seeded fibrillization of recPrP from the same or other species to mimic in
vitro the natural species barrier. We could show that the in vitro system of seeded fibrillization is in accordance with what is
known from the naturally occurring species barriers.
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Introduction
Prion diseases are fatal progressive neurodegenerative diseases
of spontaneous, genetic, or infectious origin. The conversion of the
host encoded prion protein (PrP
C) into the disease causing isoform
PrP
Sc is the key molecular event in prion disease. The common
hypothesis is, that the amplification of PrP
Sc is achieved by the
conversion of the a-helical dominated cellular isoform PrP
C into b-
sheet rich and insoluble PrP
Sc while PrP
Sc acts as template and
catalyst for PrP
C conversion [1]. The pool of PrP
C is replenished
by the cellular synthesis of PrP
C. Some mechanistic models have
been suggested, including the heterodimer model [2], the
cooperative model [3], and the model of seeded polymerization
[4]. Most experimental data support the seeded polymerization.
Prion diseases are not only transmissible within one species, but in
some cases also between different species [5]. This so called
‘‘interspecies transmission’’ is of special interest since the origin of
bovine spongiform encephalopathy is suspected to be caused by
feeding meat and bone meal from Scrapie infected sheep to cattle,
i.e. an interspecies transmission might have lead to the BSE-
epidemic in the UK [6]. In an experimental approach it was
indeed shown that cattle are susceptible to infection by sheep
Scrapie isolates [7]. On the other hand it is known that
interspecies transmission can fail e.g. Syrian hamster Scrapie is
not transmissible to mice [8]. In that case the interspecies barrier
would be too high for experimental observation. The molecular
mechanism of prion disease transmissibility between different
species is still not understood.
A molecular model for the infectious process of prions is the
conversion of PrP
C to PrP
Sc induced by the invading PrP
Sc.A s
mentioned above, the widely accepted mechanistic model is that of
PrP
Sc acting as seed for polymerization of PrP
C [9,4,10]. To study
the mechanism of spontaneous and seed-depended fibrillization of
recPrP different in vitro conversion assays were introduced, which
lead to the formation of amyloid fibrils [11,12,13]. The in vitro
conversion into amyloid led to the first generation of synthetic
prions utilizing only murine recPrP [14], i.e. without PrP
Sc as seed,
which would represent a model for the sporadic case of prion
diseases.
In the present study we use the SDS PrP conversion system to
simulate intra- and interspecies transmission in vitro. It is a minimal
system in the sense, that only recPrP as substrate, buffer, and
purified PrP
Sc as seed, but no cellular extract is needed. We extend
the spontaneous and seed depended conversion, established for
recombinant Syrian hamster PrP [11] and bovine recPrP [15], to
recombinant ovine and murine PrP. It has been shown earlier that
well balanced concentrations of sodium chloride and SDS have to
be chosen for every substrate PrP in order to guarantee a suitable
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e14283extent of partial denaturation, which is a prerequisite for
fibrillization, spontaneous as well as seeded fibrillzation.
To monitor amyloid formation of recPrP we used the amyloid
specific marker Thioflavin T (ThT). We are able to mimic the
species barrier in vitro in complete accordance with the species
barrier as found with the in vitro infection of prions.
Results
In our previous studies we analyzed spontaneous and PrP
Sc-
seeded fibril formation of recombinant PrP (recPrP). Buffer
conditions were established which consist of well selected SDS
and NaCl concentrations, so that recPrP forms spontaneously
amyloid fibrils within weeks, but the fibril formation was
accelerated by seeding with PrP
Sc to hours or days. It is important
to note, that the optimal buffer conditions had to be selected for
the species of recPrP during spontaneous fibril formation, and
these conditions were used for seeded fibril formation. It was
discussed earlier that the buffer conditions allow a particular
extent of partial denaturation of recPrP in a well characterized
pre-amyloid state. Spontaneous and seeded fibril formation of
recPrP was analyzed with bovine and hamster recPrP as substrate
and the homologous NaPTA-precipitated PrP
Sc as seeds [11,15].
In the present study, we established conditions for spontaneous
and seeded fibril formation of recPrP from sheep (aminoacids: 25–
233) and mouse (aminoacids 89–231). The aim of this study was to
combine recPrP-substrates and PrP
Sc-seeds of different species to
investigate if the fibril formation in vitro does resemble the well
known phenomenon of species barrier for transmissibility. In our
system the species barrier phenomena are studied on the level of
the molecular interaction of PrP and PrP
Sc.
Spontaneous fibril formation of recombinant ovine and
murine prion protein
To determine optimal buffer conditions in which ovine PrP
(OvPrP(25–233)) forms amyloid fibrils, we analyzed OvPrP(25–233)
fibril formation in 10 mMNaPi, 250 mM NaCl by varying the SDS-
concentration from 0.01 to 0.05%. Fibril formation was followed in
the Thioflavin T assay. Incubation was carried out at 37uCu n d e r
constant agitation for 4 weeks and fibrils could be observed at 0.02%
SDS after three to four weeks (fig. 1A). The fibrillar character of
OvPrP(25–233) was verified by electron microscopy (fig. 1B). At
higher or lower SDS-concentrations amyloid specific fluorescence
increase could not be observed. Therefore in all the following
experiments with OvPrP(25–233), the buffer was NaPi pH 7.2,
250 mM NaCl and 0.02% SDS. As mentioned above amyloid
formation depends upon of a specific pre-amyloid state of recPrP as
long as it is soluble [11,15]. Therefore we analyzed also the pre-
amyloid state of OvPrP(25–233). The secondary structure, revealed
with circular dichroism, showed in some contrast to formerly
analyzed initial-states a higher random-coil amount (fig. 1C). A
comparison of the secondary structure analysis of different species are
shown in Text S1. In line with previous studies [11] the analytical
ultracentrifucation data revealed an equilibrium of monomeric (33%)
and dimeric (67%) OvPrP(25–233) (fig. 1D, Text S1).
Buffer conditions for fibril formation of murine recPrP
(MuPrP(89–231)) were analyzed in the same way. It was found
that a wider SDS-range was suitable for fibril formation, with an
optimum at 0.04% SDS in NaPi pH 7.4, 250 mM (data not
shown).
Intraspecies PrP
Sc-seeded amyloid formation
In previous studies we showed that NaPTA-precipitated PrP
Sc
from brain homogenate works very well as seed and could
drastically accelerate fibril formation. As a control, NaPTA-
precipitate from brain homogenate of uninfected animals did not
show any acceleration effect. The presence of the N-terminal
sequence (aminoacids 23–89) had no influence on the seeding
effect (Text S1). For the ovine system, NaPTA-precipitated PrP
Sc
from brain tissue of Scrapie-infected sheeps (OvPrP
Sc) was used as
seed and accelerated fibril formation was observed based on the
increase of ThT-fluorescence within 10 to 20 hours (fig. 2A). The
approach was carried out with 40 ng/ml rec OvPrP(25–233)
(1.8 mM) in conversion buffer and 0.02% SDS.
We also adopted the seed dependent fibril formation for
MuPrP. NaPTA-precipitated PrP
Sc from mouse brain accelerated
the process down to 10 to 20 hours (fig. 2B) while the spontaneous
formation of amyloids takes at least 7 days (data not shown). As a
control NaPTA-precipitate of non-infected mouse brain tissue did
not lead to any formation of amyloidogenic fibrils in the time
range of the experiment.
In vitro species barrier
The aim of this study was to analyze the species barrier of prion
infection in vitro, i.e. with PrP
Sc-seeds and otherwise purified
components only. From natural and experimental transmission
data it is known that prion diseases are transmissible in some cases
from one species to another and in other cases not. This
phenomenon is commonly known as species barrier. PrP
Sc from
brain homogenate of one species was taken as seeds and recPrP of
another species as template. Transmission was simulated by
fibrillzation in our in vitro conversion assay with the exact
concentrations of that particular species.
As an example of interspecies transmission of ovine Scrapie to
cattle as recipient [7] is shown in fig. 2C using OvPrP
Sc as seed
and BovPrP(25–241) as substrate. Accelerated fibril formation of
BovPrP by OvPrP
Sc-seed is clearly observed, very similar to the
intraspecies seeded fibrillization in sheep (fig. 2A).
In another experiment, murine recPrP was seeded with prions
from Scrapie infected hamster. In contrast to the intraspecies
seeded fibrillization of MuPrP(89–231) (fig. 2B), no increase of the
ThT-fluorescence was measured within a time period of 48 hours
(fig. 2D). This shows, that SHaPrP
Sc does not act as seed for
accelerated fibril formation of MuPrP(89–231). This corresponds
to the well known species barrier between Syrian hamster Scrapie
and mouse as recipient [8]. In all seeded fibrillization experiments,
i.e. intraspecies as well as interspecies combinations, NaPTA-
precipitate of brain tissue from non-infected animals served as
controls and did not lead to an increased fluorescence read out
within the timescale of the experiments (fig. 2 blue lines).
Figure 3 gives an overview of the fluorescence readouts of
various seed - substrate combinations. The ThT-fluorescence
intensities in the time period of 24 to 48 hours of incubation and
after seeding were summarized. Interspecies transmission is
obvious for five different combinations of PrP
Sc-seeds and recPrP
substrate: OvPrP
Sc to SHaPrP(90–231), OvPrP
Sc to BovPrP(25–
241), SHaPrP
Sc to OvPrP(25–233), SHaPrP
Sc to BovPrP(25–241)
and BovPrP
Sc to OvPrP(25–233). In our system, approach two
well known in vivo interspecies barriers [8] [16] could be simulated
with our in vitro, conversion system namely the species barrier of
BSE to Syrian Hamster as well as of Syrian Hamster Scrapie to
mouse. In summary, all of our in vitro intra- and interspecies
transmission results resemble exactly the in vivo situation (table 1).
Discussion
Conversion of the cellular prion protein (PrP
C) to PrP
Sc is the
key event in prion infection [2]. Although many studies with
Prion Species Barrier
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out the molecular mechanism is still not well understood [17]
[18,19]. These studies are based mainly on the simulation of the
structural properties of PrP
Sc like b-sheet content, PK-resistance or
morphology of amyloid fibrils. However these systems have not
generated infectious PrP or only very low titers of infectivity were
generated spontaneously [14]. Recently, the group of S.B. Prusiner
and colleagues could show that subtle variations in the structure of
in vitro generated fibrils give rise to a variety of infectious
preparation with distinct strain properties [20]. In contrast to
spontaneous fibrillization seed-dependent assays like protein
misfolding cyclic amplification (PMCA) [21] and quaking-induced
conversion (Quic) [22] were established and are in very good
agreement with the infectious etiology of prion diseases. Both
assays are carried out in cellular extracts from uninfected animals
or cells, which cannot exclude the involvement of cellular
compounds in the conversion reaction.
Our group established a SDS-based conversion assay that works
without cellular extracts, using solely purified compounds, like
phosphate buffer, recPrP as substrate and prepurified PrP
Sc as
seed [11]. The use of partially denaturing conditions in conversion
of recombinant PrP into amyloid with physiochemical properties
reminiscent of PrP
Sc seems to be a general concept in in vitro
conversion studies of PrP and were studied in greater detail
[18,22]. Beside those classical protein denaturants other com-
pounds have been identified (e.g. glycosaminclycans and oligonu-
Figure 1. Characterization of spontaneous OvPrP(25–233) fibril formation within the in vitro conversion system. A: Dependence of
OvPrP(25–233) amyloid formation on SDS-concentration. OvPrP(25–233) was incubated in 10 mM NaPi pH 7.4, 250 mM NaCl and 0.01–0.05% SDS.
The amount of fibril formation was measured by ThT-fluorescence. Thioflavin T was added to a final concentration of 5 mM to 10 ng/ml OvPrP(25–
233). B: Electron micrographs show the typical structure of amyloid fibrils after 7 days of incubation of OvPrP(25–233) in 10 mM NaPi pH 7.4, 250 mM
NaCl 0.02% SDS (bar=20 nm). C: Secondary structure analysis of the pre-amyloid state. CD-spectra were measured directly after adapting the SDS
conditions, with a final concentration of 150 ng/ml OvPrP(25–233) in 10 mMNaPi pH 7.4 and 250 mMNaCl. D: Sedimentation equilibrium
centrifugation of OvPrP(25–233) after 7 days of incubation. (left) Experimental data overlaid by the fitted curves (right) residuals.
doi:10.1371/journal.pone.0014283.g001
Prion Species Barrier
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influence on PrP remains unknown [23,24].
PMCA and Quic were mainly developed for diagnostic
purposes, our system with the well defined components was
developed to describe quantitatively the prion propagation
mechanism using hamster PrP. This SDS-based conversion assay
was applied to additional species, in order to test if our conversion
system can be used with prion proteins of different species and if
the pre-amyloid state described with hamster PrP represent a
general mechanism for amyloid formation in our in vitro
conversion system. Furthermore, by combining seed and substrate
from different species we have the opportunity to simulate the
phenomena of species barriers for the first time on the level of a
direct molecular interaction of prion seed and recPrP substrate
without the influence of any other cellular component. In the
presented study we were able to show that amyloid fibrils of recPrP
can be formed within the SDS-based conversion system for all
species investigated (cattle, sheep, mouse, hamster). Only the SDS
concentration had to be adapted. These results and the properties
of the intermediate state will be discussed on a more detailed level
later. The phenomenon of species barrier for prion transmission
was successfully modeled as seed dependent in vitro fibrillization.
Five interspecies transmissions have been observed (fig. 3). Not
very surprisingly, the amyloid formation of interspecies transmis-
sion seems to be slower as compared to intraspecies transmission
(fig. 2). Two interspecies transmissions were reported to have failed
(SHaPrP
Sc to MuPrP(89–231) and BovPrP
Sc to SHaPrP(90–231)).
Consequently, also a strict species barrier was found in the in vitro
simulation (fig. 3). For murine substrate, only one positive
transmission (MuPrP
Sc to MuPrP(89–231)) and one negative
(SHaPrP
Sc to MuPrP(89–231)) could be performed for reasons of
shortage of mouse prions in our lab. As a main result of our work
we found that the in vitro simulation of the species barrier is in
complete agreement with the experimental data from in vivo
transmission studies (Tab. 1). Similar results on interspecies
transmission and species barrier were reported by studies with
PMCA [25] and by Cashman and co-workers [26], whereby both
systems use cellular extracts. Because our conversion system does
not include cellular extracts we conclude that the species barrier is
encoded within the direct interaction of PrP
Sc and PrP
C [27].
Interspecies transmission as well as species barrier is well
resembled in our system. Cellular factors might be beneficial for
the conversion reaction, but only by enforcing the pre-existing
interaction.
The interpretation of our results on the molecular level shows
the importance of partial denaturation of recPrP as substrate as
described by Sto ¨hr et al. [11]. PrP in this intermediate or pre-
amyloid state is soluble for weeks, suggesting that it is in a state of
low free energy. Since it is present in a monomer-dimer-
equilibrium one can argue that the partially denaturated PrP is
prone to intermolecular interactions possibly also with PrP
Sc.
However in our conversion conditions PrP is in the state of lowest
Figure 2. Kinetics of intra- and interspecies seeded recPrP amyloid formation. Amyloid formation of recPrP was monitored using ThT-
fluorescence assay in 10 mM NaPi (pH 7.4) with 250 mM NaCl (at 37uC). In vitro intraspecies transmission: (A) Amyloid formation of 1.8 mM (40 ng/ml)
OvPrP(25–233)-substrate seeded with OvPrP
Sc in 0.02% SDS (red line), (B) of 1.8 mM (30 ng/ml) MuPrP(89–231)-substrate seeded with MuPrP
Sc in
0.04% SDS (red line). In vitro interspecies transmission: (C) Amyloid formation of BovPrP(25–241)-substrate seeded with OvPrP
Sc in 0.02% SDS (red
line). In vitro interspecies barrier: (D) In presence of SHaPrP
Sc no MuPrP(89–231) amyloid formation occurs (red line). NaPTA-precipitate of
corresponding same treated brain tissue from healthy animals: blue line.
doi:10.1371/journal.pone.0014283.g002
Prion Species Barrier
PLoS ONE | www.plosone.org 4 December 2010 | Volume 5 | Issue 12 | e14283free energy if it is refolded for attachment to the fibrillar seed. We
assume that this state is not present in measurable amounts in
solution but only attached to the seed. The degree of denaturation
in the intermediate state is critical; for different recPrP sequences,
i.e. for different species, different SDS concentrations are needed.
More than the optimal SDS concentration would lead to a more
unfolded PrP
C whereas less SDS leads to a more refolded PrP
C
state as compared to the optimal intermediate state. In both cases
the conversion of PrP to fibrillar PrP would be too slow to be
observable. For an interspecies transmission a partially unfolded
state of the substrate PrP is required, but DG for substrate (PrP
refolded in the complex) with the seed from the other species in the
same way as for intraspecies transmission has to be sufficiently low,
i.e. lower than in the intermediate state, to guarantee the
transition. In summary not the intermediate state of substrate
PrP is critical for transition but its potency to refold into a
conformation well adapted to the PrP
Sc-seed.
In future experiments we will extend our experimental
approach to other species like human CJD and cervid CWD.
Due to the high occurrence of CWD in Northern America, the
combination of CWD-seed and human PrP as substrate would be
of particular interest.
Materials and Methods
Recombinat Prion Proteins
The recombinant prion protein (recPrP) was prepared and
purified as described previously [28,29]. The recPrP with the
amino acid sequence of Syrian Hamster (90–231) (SHaPrP) PrP as
well as recPrP with the amino acid sequence of cattle (25–241)
(BovPrP) PrP was used in our studies before [15]. We adopted the
purification protocols to full length recombinant ovine PrP (25–
233) (OvPrP). Recombinant murine PrP (89–231) (MuPrP) was
acquired from Allprion (Schlieren, Switzerland).
NaPTA precipitation of PrP
Sc
PrP
Sc from brain tissue of different species was purified by
NaPTA (Sodium phosphotungstate dibasic hydrate) precipitation
[30,31] Additionally to Syrian hamster and bovine PrP
Sc
(SHaPrP
Sc and BovPrP
Sc) [11,15] we adopt the purification
protocol to ovine PrP
Sc (OvPrP
Sc) and to Murine PrP
Sc (MuPrP
Sc).
Figure 3. Comparison of different interspecies recPrP seeding. Amyloid formation in the seeding assay was monitored using Thioflavin T. The
fluorescence signals were recorded every 30 min at 37uC at recPrP amyloid forming conditions. Fluorescence intensities were summarized from 24–
48 h (saturation phase). (Left to right) Interspecies transmission: OvPrP
Sc in SHaPrP(90–231); OvPrP
Sc in BovPrP(25–241); SHaPrP
Sc in OvPrP(25–233);
SHaPrP
Sc in BovPrP(25–241); BovPrP
Sc in OvPrP(25–233). Interspecies barrier: BovPrP
Sc in SHaPrP(90–231); SHaPrP
Sc in MuPrP(89–231). As control
parallel an approach was made with the corresponding intraspecies transmission (data not shown).
doi:10.1371/journal.pone.0014283.g003
Table 1. In vivo vs. In vitro intraspecies and interspecies
transmission and species barrier.
in vivo
BovPrP OvPrP SHaPrP MuPrP
BovPrP
Sc + + 2 +
OvPrP
Sc + + + +
SHaPrP
Sc (+)( +) + 2
MuPrP
Sc (+)( +) + +
in vitro
BovPrP OvPrP SHaPrP MuPrP
BovPrP
Sc + + 2 n.d.
OvPrP
Sc + + + n.d.
SHaPrP
Sc + + + 2
MuPrP
Sc n.d. n.d. n.d. +
+ = Intraspecies transmission; + = Interspecies transmission; 2 = Interspecies
barrier; (+) = transmission studies in transgenic mice; n.d. not determined.
doi:10.1371/journal.pone.0014283.t001
Prion Species Barrier
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sonification (Sonificator, Labsonic U, Braun Dissel, Melsungen).
Circular dichroism spectroscopy
Circular dichroism (CD) spectra were recorded with a J-715
spectropolarimeter (Jasco, Easton, MD, USA) in a 0.1 cm quartz
cuvette at room temperature. The scanning speed was 50 nm/min
with resolution of 1 nm. For each sample 10 spectra were
accumulated between 195 and 260 nm. The protein concentration
was 150 ng/ml. Background spectra of buffer samples were
subtracted from the respective protein spectra.
Analytical Ultracentrifugation
Sedimentation-diffusion equilibrium experiments were per-
formed, as described in ref [11], in a Beckman Optima XL-A
analytical ultracentrifuge (Beckman Coulter) applying standard
12-mm double-sector cells at 20uC. The data were analyzed by
using the Global Fit procedure, which is implemented in the
UltraScan II software package (Version 5.0 for UNIX) of B.
Demeler (University of Texas Health Science Center, San
Antonio, TX).
Electron microscopy, negative stain
A droplet of 5–10 ml containing the recPrP was placed on glow
discharged grid and left to adsorb for 2 minutes. After adsorption
to the grid surface the sample was washed briefly (50 ml of: 0.1 and
0.01 M NH4 acetate) and stained with 2% ammoniummolybdate
(50 ml). The samples were analyzed with a Zeiss EM910
microscope at 80 kV.
Thioflavin T-Assay
Fluorescence emission spectra of Thioflavin T (ThT) were
measured at a concentration of 5 mM ThT and 10 ng/ml recPrP in
150 ml 10 mM NaPi pH 7.4. The emission spectra were recorded
from 460 nm to 630 nm with a fixed excitation wavelength of
455 nm, average of lem 495 to 505 is shown for a time point.
Fibrillization kinetics were followed in 96 well plates according to
Sto ¨hr et al. [11]. All measurements were performed in a Tecan
saphire plate reader (Tecan Group, Maennedorf, Switzerland).
The chosen regression line is polynomial fitted to original data
points.
Spontaneous and seeded amyloid formation of recPrP
Spontaneous and seeded amyloid fibril formation of recPrP of
the different species was monitored by ThT-assay as described
above. The buffer conditions especially the SDS-concentrations
were adjusted according to the amyloid forming conditions of the
spontaneous case for each species. The results are displayed as sum
of the average fluorescence intensities of 495 to 505 nm in the
saturation phase (24 h to 48 h in 30 min interval) of the curve. To
determine the specificity of the seeding effect in interspecies
transmission or interspecies barrier NaPTA-precipitated PrP
Sc
from brain tissue of infected and non-infected animals was
compared.
Supporting Information
Text S1 Including supporting figures and tables.
Found at: doi:10.1371/journal.pone.0014283.s001 (0.13 MB
DOC)
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